Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Elevating the Levels of Calcium Ions Exacerbate Alzheimer’s Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau
Peipei Guan, Long‐Long Cao, Pu Wang
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5900-5900
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Inflammatory Processes in Alzheimer’s Disease—Pathomechanism, Diagnosis and Treatment: A Review
Bartosz Twarowski, Mariola Herbet
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6518-6518
Open Access | Times Cited: 94
Role of Microglia and Astrocytes in Alzheimer’s Disease: From Neuroinflammation to Ca2+ Homeostasis Dysregulation
Giulia Di Benedetto, Chiara Burgaletto, Carlo Maria Bellanca, et al.
Cells (2022) Vol. 11, Iss. 17, pp. 2728-2728
Open Access | Times Cited: 80
Aducanumab—Hope or Disappointment for Alzheimer’s Disease
Karolina Wojtunik‐Kulesza, Monika Rudkowska, Anna Orzeł-Sajdłowska
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4367-4367
Open Access | Times Cited: 44
Passive immunotherapy for Alzheimer's disease
Xiaoyi Guo, Yan Li, Denghong Zhang, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102192-102192
Open Access | Times Cited: 24
Dysfunctional Glucose Metabolism in Alzheimer’s Disease Onset and Potential Pharmacological Interventions
Vijay Kumar, So-Hyeon Kim, Kausik Bishayee
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9540-9540
Open Access | Times Cited: 59
Role of Calcium Modulation in the Pathophysiology and Treatment of Alzheimer’s Disease
Daniela Baracaldo-Santamaría, Sara Sofia Avendaño-Lopez, Daniel Felipe Ariza-Salamanca, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 9067-9067
Open Access | Times Cited: 40
Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond
Elise K. Webber, Marc Fivaz, Grace E. Stutzmann, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 8, pp. 3701-3717
Open Access | Times Cited: 23
Exome sequencing reveals a rare damaging variant in GRIN2C in familial late-onset Alzheimer's disease
Elisa Rubino, Maria Italia, Elisa Di Giorgio, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Nonequilibrium landscape of amyloid-beta and calcium ions in application to Alzheimer's disease
Swadesh Pal, Roderick Melnik
Physical review. E (2025) Vol. 111, Iss. 1
Closed Access | Times Cited: 1
Reinforcing Nrf2 Signaling: Help in the Alzheimer’s Disease Context
Annamaria la Torre, Filomena Lo Vecchio, Valentina Soccorsa Angelillis, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1130-1130
Open Access | Times Cited: 1
Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer’s Disease: Towards a Personalized Polypharmacology Patient-Centered Approach
Xavier Morató, Vanesa Pytel, Sara Jofresa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9305-9305
Open Access | Times Cited: 32
Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights
Kushagra Nagori, Kartik T. Nakhate, Krishna Yadav, et al.
Future Pharmacology (2023) Vol. 3, Iss. 4, pp. 877-907
Open Access | Times Cited: 18
The Complex Interplay between Toxic Hallmark Proteins, Calmodulin-Binding Proteins, Ion Channels, and Receptors Involved in Calcium Dyshomeostasis in Neurodegeneration
Danton H. O’Day
Biomolecules (2024) Vol. 14, Iss. 2, pp. 173-173
Open Access | Times Cited: 6
Polymeric nanoparticles: A promising strategy for treatment of Alzheimer's disease
Yasmina Elmahboub, Amal Elkordy
Journal of Taibah University Medical Sciences (2024) Vol. 19, Iss. 3, pp. 549-565
Open Access | Times Cited: 6
A multi‐hit hypothesis for an APOE4‐dependent pathophysiological state
Oliver Steele, Alexander Cameron Stuart, Lucy J. Minkley, et al.
European Journal of Neuroscience (2022) Vol. 56, Iss. 9, pp. 5476-5515
Open Access | Times Cited: 24
The Sigma Receptors in Alzheimer’s Disease: New Potential Targets for Diagnosis and Therapy
Tao Wang, Hongmei Jia
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12025-12025
Open Access | Times Cited: 15
The research trends and hotspots of NLRP3 inflammasome in Alzheimer's disease: a bibliometric and visualization analysis
Xuanwei Wen, Huiye Yang, Shuangxi Chen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Cognitive resilience in Alzheimer’s disease: mechanism and potential clinical intervention
Bin Jia, Yun Xu, Xiaolei Zhu
Ageing Research Reviews (2025) Vol. 106, pp. 102711-102711
Closed Access
Coenzyme Q10 alleviates AlCl3 and D-galactose induced Alzheimer via modulating oxidative burden and TLR-4/MAPK pathways and regulation microRNA in rat brain
Nagat F. Nawar, Doha M. Beltagy, Ehab Tousson, et al.
Toxicology Research (2025) Vol. 14, Iss. 2
Closed Access
Alzheimer’s Disease Drug Design by Synthesis, Characterization, Enzyme Inhibition, In Silico, SAR Analysis and MM-GBSA Analysis of Schiff Bases Derivatives
Halis Karataş, İlayda Bersu Kul, Meltem Aydin, et al.
Korean Journal of Chemical Engineering (2025)
Open Access
Unveiling the role of Na⁺/K⁺-ATPase pump: neurodegenerative mechanisms and therapeutic horizons
Ramandeep Kaur Sidhu, Kousik Maparu, Shamsher Singh, et al.
Pharmacological Reports (2025)
Closed Access
Calcium Ions Aggravate Alzheimer’s Disease Through the Aberrant Activation of Neuronal Networks, Leading to Synaptic and Cognitive Deficits
Peipei Guan, Long‐Long Cao, Yi Yang, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 30
The STIM1/2-Regulated Calcium Homeostasis Is Impaired in Hippocampal Neurons of the 5xFAD Mouse Model of Alzheimer’s Disease
Ksenia Skobeleva, Alexey Shalygin, Elena R. Mikhaylova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14810-14810
Open Access | Times Cited: 20
New Insights into Alzheimer’s Disease: Novel Pathogenesis, Drug Target and Delivery
Haishu Chen, Jinan Xu, Hanyuan Xu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1133-1133
Open Access | Times Cited: 9
Exploring the Role of NCX1 and NCX3 in an In Vitro Model of Metabolism Impairment: Potential Neuroprotective Targets for Alzheimer’s Disease
Alessandra Preziuso, Silvia Piccirillo, Giorgia Cerqueni, et al.
Biology (2023) Vol. 12, Iss. 7, pp. 1005-1005
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top